32.74
price up icon2.15%   0.69
after-market Handel nachbörslich: 32.74
loading

Akero Therapeutics Inc Aktie (AKRO) Neueste Nachrichten

pulisher
11:42 AM

Akero Therapeutics COO sells $1.6 million in stock By Investing.com - Investing.com South Africa

11:42 AM
pulisher
11:33 AM

Akero Therapeutics COO sells $1.6 million in stock - Investing.com India

11:33 AM
pulisher
10:08 AM

Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells $1,601,104.12 in Stock - MarketBeat

10:08 AM
pulisher
09:19 AM

Akero Therapeutics CEO Andrew Cheng sells $3.4 million in stock By Investing.com - Investing.com South Africa

09:19 AM
pulisher
09:18 AM

Akero Therapeutics CEO Andrew Cheng sells $3.4 million in stock - Investing.com India

09:18 AM
pulisher
Nov 04, 2024

abrdn plc Sells 75,879 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Nov 04, 2024
pulisher
Nov 02, 2024

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 4,515 Shares of Stock - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Akero Therapeutics chief development officer sells $651,960 in stock By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Akero Therapeutics chief development officer sells $651,960 in stock - Investing.com

Nov 01, 2024
pulisher
Oct 29, 2024

Akero Therapeutics (NASDAQ:AKRO) Trading Up 5.8%Here's What Happened - MarketBeat

Oct 29, 2024
pulisher
Oct 27, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) Sees Significant Decline in Short Interest - MarketBeat

Oct 27, 2024
pulisher
Oct 21, 2024

Akero Therapeutics to Present Data Reinforcing the Efficacy - GlobeNewswire

Oct 21, 2024
pulisher
Oct 21, 2024

Akero Therapeutics to Present Data Reinforcing the Efficacy of Efruxifermin at the 75th Annual AASLD The Liver Meeting® 2024 - StockTitan

Oct 21, 2024
pulisher
Oct 20, 2024

Akero Therapeutics Insiders Sell US$1.2m Of Stock, Possibly Signalling Caution - Simply Wall St

Oct 20, 2024
pulisher
Oct 19, 2024

(AKRO) Proactive Strategies - Stock Traders Daily

Oct 19, 2024
pulisher
Oct 18, 2024

Andrew Cheng Sells 24,992 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Akero Therapeutics CEO Andrew Cheng sells $2.88 million in stock By Investing.com - Investing.com Canada

Oct 18, 2024
pulisher
Oct 18, 2024

Akero Therapeutics chief development officer sells $636,490 in stock By Investing.com - Investing.com South Africa

Oct 18, 2024
pulisher
Oct 18, 2024

Akero Therapeutics chief development officer sells $636,490 in stock - Investing.com India

Oct 18, 2024
pulisher
Oct 17, 2024

State Street Corp's Strategic Reduction in Akero Therapeutics Inc Shares - GuruFocus.com

Oct 17, 2024
pulisher
Oct 17, 2024

Akero therapeutics COO Jonathan Young sells $1.2 million in stock By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 17, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by Rheos Capital Works Inc. - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) Sees Significant Decrease in Short Interest - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Akero therapeutics COO Jonathan Young sells $1.2 million in stock - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Catriona Yale Sells 6,136 Shares - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Akero Therapeutics (AKRO): Leading the Charge in MASH Treatment with Efruxifermin - Insider Monkey

Oct 16, 2024
pulisher
Oct 15, 2024

Akero Therapeutics, Inc. (AKRO): A Visionary Small-Cap Stock Pick by Hedge Funds - Insider Monkey

Oct 15, 2024
pulisher
Oct 15, 2024

Should investors be concerned about Akero Therapeutics Inc (AKRO)? - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Statistics, Drugs, Mechanism of Action, Route of Administration, and Companies by DelveInsight - The Globe and Mail

Oct 15, 2024
pulisher
Oct 14, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Oct 14, 2024
pulisher
Oct 12, 2024

10 Most Promising Small-Cap Stocks According to Hedge Funds - Insider Monkey

Oct 12, 2024
pulisher
Oct 12, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Oct 12, 2024
pulisher
Oct 10, 2024

The Manufacturers Life Insurance Company Purchases 22,195 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Akero Therapeutics Inc [AKRO] Investment Appeal on the Rise - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

AKRO’s 2023 Market Dance: Up 20.56% – Time to Invest? - The InvestChronicle

Oct 09, 2024
pulisher
Oct 08, 2024

Akero Therapeutics (NASDAQ:AKRO) Shares Up 4.2%Here's Why - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

A better buy-in window may exist right now for Akero Therapeutics Inc (AKRO) - SETE News

Oct 07, 2024
pulisher
Oct 04, 2024

A company insider recently sold 10,000 shares of Akero Therapeutics Inc [AKRO]. Should You Sale? - Knox Daily

Oct 04, 2024
pulisher
Oct 04, 2024

Algert Global LLC Decreases Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Akero Therapeutics COO sells $281,770 in company stock - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells $281,800.00 in Stock - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Is Akero Therapeutics Inc (AKRO) a good investment opportunity? - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

The Potential Rise in the Price of Akero Therapeutics Inc (AKRO) following insiders activity - Knox Daily

Oct 01, 2024
pulisher
Sep 30, 2024

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to Contact Law Firm - Longview News-Journal

Sep 30, 2024
pulisher
Sep 30, 2024

Top investors say Akero Therapeutics Inc (AKRO) ticks everything they need - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Perceptive Advisors LLC Purchases 112,426 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Akero Therapeutics to Present at the H.C. Wainwright 8th Annual MASH Virtual Conference - StockTitan

Sep 30, 2024
pulisher
Sep 28, 2024

Akero Therapeutics Inc (AKRO) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register

Sep 28, 2024
pulisher
Sep 28, 2024

(AKRO) Investment Analysis and Advice - Stock Traders Daily

Sep 28, 2024
pulisher
Sep 27, 2024

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus.com

Sep 27, 2024
pulisher
Sep 27, 2024

A company insider recently sold 5,500 shares of Akero Therapeutics Inc [AKRO]. Should You Sale? - Knox Daily

Sep 27, 2024
pulisher
Sep 27, 2024

Akero Therapeutics (NASDAQ:AKRO) Trading Down 2.7% - MarketBeat

Sep 27, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):